{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:31:05Z","timestamp":1771273865661,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.tracli.2003.12.003","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T06:25:52Z","timestamp":1075184752000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Should HBV DNA NAT replace HBsAg and\/or anti-HBc screening of blood donors?"],"prefix":"10.1016","volume":"11","author":[{"given":"Michael P","family":"Busch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2003.12.003_BIB1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1537-2995.2001.41091081.x","article-title":"HBV: amplified and back in the blood safety spotlight","volume":"41","author":"Kleinman","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","article-title":"Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection","volume":"43","author":"Biswas","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1537-2995.2001.41070878.x","article-title":"Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository","volume":"41","author":"Matsumoto","year":"2001","journal-title":"Transfusion"},{"issue":"Suppl 9S","key":"10.1016\/j.tracli.2003.12.003_BIB4","first-page":"8s","article-title":"Comparative sensitivity of HBsAg and HBV NAT","volume":"41","author":"Stramer","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1537-2995.2002.00128.x","article-title":"NAT for HBV and anti-HBc testing increase safety","volume":"42","author":"Roth","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1423-0410.2003.00289.x","article-title":"Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening","volume":"84","author":"Minegishi","year":"2003","journal-title":"Vox Sang"},{"issue":"Suppl 9S","key":"10.1016\/j.tracli.2003.12.003_BIB7","first-page":"26a","article-title":"A prospective study to evaluate the screening of plasma pools from volunteer blood donations (VBD) for the presence of HBV DNA","volume":"43","author":"Pietrelli","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1537-2995.2003.00392.x","article-title":"The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations","volume":"43","author":"Jackson","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJM197806222982502","article-title":"Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen","volume":"298","author":"Hoofnagle","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2003.12.003_BIB10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1537-2995.2001.41091107.x","article-title":"Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay","volume":"41","author":"Sato","year":"2001","journal-title":"Transfusion"},{"issue":"Suppl 9S","key":"10.1016\/j.tracli.2003.12.003_BIB11","first-page":"110s","article-title":"Contribution of anti-HBc screening to blood safety at a regional blood center in the United States","volume":"37","author":"Tegtmeier","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"issue":"Suppl 9S","key":"10.1016\/j.tracli.2003.12.003_BIB13","first-page":"16s","article-title":"First year donation patterns predict long-term commitment for first-time donors","volume":"40","author":"Schreiber","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB14","unstructured":"Williams AE. Deferral of blood donors potentially exposed to the agent of variant Creutzfeldt\u2013Jakob disease (vCJD). Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC), June 28-29, 2001, Bethesda, Maryland. USA.US Dept of Health & Human Services (DHHS), Food & Drug Administration (FDA), Dockets Management Branch (DMB). http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/minutes\/3762m1.pdf"},{"key":"10.1016\/j.tracli.2003.12.003_BIB15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.tracli.2003.12.003_BIB16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern \u201canti-HBc alone\u201d: report on a workshop","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.tracli.2003.12.003_BIB17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.1999.01665.x","article-title":"Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion","volume":"107","author":"Allain","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2003.12.003_BIB18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1537-2995.1998.38198141499.x","article-title":"New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays","volume":"38","author":"Jongerius","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1537-2995.2003.00391.x","article-title":"Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening","volume":"43","author":"Kleinman","year":"2003","journal-title":"Transfusion"},{"issue":"Suppl 9s","key":"10.1016\/j.tracli.2003.12.003_BIB20","first-page":"26a","article-title":"Analysis of anti-HBc data from a prospective study to evaluate the screening of plasma pools from volunteer blood donations for the presence of HBV DNA","volume":"43","author":"Strong","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1537-2995.2001.41030329.x","article-title":"Infectivity of blood from PCR positive, HBsAg negative, anti-HBs positive cases of resolved hepatitis B infection","volume":"41","author":"Prince","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1537-2995.1995.35195090661.x","article-title":"Donor screening for antibody to hepatitis core antigen and hepatitis B virus infection in transfusion recipients","volume":"35","author":"Mosley","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1537-2995.2002.00099.x","article-title":"Mathematical modeling of the risk of HBV, HCV, and HIV transmission by window phase donations not detected by NAT","volume":"42","author":"Weusten","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2003.12.003_BIB24","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl 10s","key":"10.1016\/j.tracli.2003.12.003_BIB25","first-page":"95s","article-title":"Intermittent PCR positivity for hepatitis B viral DNA in surface antigen negative anti-core positive individuals","volume":"39","author":"Kuhns","year":"1999","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782003001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782003001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:11:49Z","timestamp":1761127909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782003001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1246782003001575"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2003.12.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should HBV DNA NAT replace HBsAg and\/or anti-HBc screening of blood donors?","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2003.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}